C20H19N3O4
Neat
365.39
183321-84-8; 4-[(3-Ethynylphenyl)amino]-6, 7-bis(2-hydroxyethoxy)quinazoline; Erlotinib metabolite M12; 2-[4-(3-ethynylanilino)-7-(2-hydroxyethoxy)quinazolin-6-yl]oxyethanol; CP-373943; OSI-943; 2, 2'-((4-((3-ethynylphenyl)amino)quinazoline-6, 7-diyl)bis(oxy))diethanol; Ethanol, 2, 2'-[[4-[(3-ethynylphenyl)amino]-6, 7-quinazolinediyl]bis(oxy)]bis-; 92T0F45VE1; 2-(4-(3-Ethynylanilino)-7-(2-hydroxyethoxy)quinazolin-6-yl)oxyethanol; Ethanol, 2, 2'-((4-((3-ethynylphenyl)amino)-6, 7-quinazolinediyl)bis(oxy))bis-; Ethanol and 2-((4-((3-ethynylphenyl)amino)-6-(2-hydroxyethoxy)-7-quinazolinyl)oxy)-; 2-({4-[(3-ethynylphenyl)amino]-6-(2-hydroxyethoxy)quinazolin-7-yl}oxy)ethan-1-ol; UNII-92T0F45VE1; Erlotinib impurity 128; SCHEMBL1507594; DTXSID40581464; Erlotinib Hydrochloride Impurity B; AKOS015907687; Q27271527
2-[4-(3-ethynylanilino)-7-(2-hydroxyethoxy)quinazolin-6-yl]oxyethanol
InChI=1S/C20H19N3O4/c1-2-14-4-3-5-15(10-14)23-20-16-11-18(26-8-6-24)19(27-9-7-25)12-17(16)21-13-22-20/h1,3-5,10-13,24-25H,6-9H2,(H,21,22,23)